Company: DRTSW
Filing Date: 2025-04-28
Form Type: 424B5
Source: 0001213900-25-035799
Chunk: 86

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-04-28
Form: 424B5
Chunk 86
---
, any agent will be acting on a commercially reasonable efforts basis for the period of its appointment.

Sales to or through one
or more underwriters or agents in at-the-market offerings will be made pursuant to the terms of a distribution agreement with
the underwriters or agents. Such underwriters or agents may act on an agency basis or on a principal basis. During the term of any such
agreement, shares may be sold on a daily basis on any stock exchange, market or trading facility on which the ordinary shares are traded,
in privately negotiated transactions or otherwise as agreed with the underwriters or agents. The distribution agreement will provide
that any ordinary share sold will be sold at negotiated prices or at prices related to the then prevailing market prices for our ordinary
shares. Therefore, exact figures regarding proceeds that will be raised or commissions to be paid cannot be determined at this time and
will be described in a prospectus supplement. Pursuant to the terms of the distribution agreement, we may also agree to sell, and the
relevant underwriters or agents may agree to solicit offers to purchase, blocks of our ordinary shares or other securities. The terms
of each such distribution agreement will be described in a prospectus supplement.

We may authorize underwriters,
dealers or agents to solicit offers by certain purchasers to purchase the securities at the public offering price set forth in the prospectus
supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the future. The contracts
will be subject only to those conditions set forth in the prospectus supplement, and the prospectus supplement will set forth any commissions
paid for solicitation of these contracts.

Underwriters and agents
may be entitled under agreements entered into with us to indemnification by us against certain civil liabilities, including liabilities
under the Securities Act, or to contribution with respect to payments which the underwriters or agents may be required to make.

The prospectus supplement
may also set forth whether or not underwriters may over-allot or effect transactions that stabilize, maintain or otherwise affect the
market price of the securities at levels above those that might otherwise prevail in the open market, including, for example, by entering
stabilizing bids, effecting syndicate covering transactions or imposing penalty bids.

Underwriters and agents
may be customers of, engage in transactions with, or perform services for us and our affiliates in the ordinary course of business.

Each series of securities
will be a new issue of securities and will have no established trading market, other than our ordinary